Stay updated with breaking news from Its Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Immunic, Inc. / Key word(s): Study Immunic Completes Enrollment of Its Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis 17.08.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Completes Enrollment of Its P...
OMO-103 in Phase 1b clinical trial Peptomyc logo Peptomyc logo BARCELONA, Spain, July 27, 2023 (Newswire.com) - Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for can...
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 ...
/PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd together with its subsidiaries, is pleased to announce that Xuanzhu Biopharmaceutical Co., Ltd....
CHANGSHA, China, May 18, 2023 /PRNewswire/ -- On May 10th and 11th, SINOBOOM, a prominent manufacturer of MEWPs (Mobile Elevating Work Platforms) that specializes in researching, manufacturing